Hologic (HOLX) Wins Appeal on Patent Validity for SenoRx Case; Invalid Ruling Reversed
Bloomberg reporting that Hologic (Nasdaq: HOLX) has won an appeal on patent validity in its SenoRx case.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merrill Lynch Will Pay $415M to Settle SEC Investigation (BAC)
- Network-1 Technologies (NTIP) Settles Patent Litigation With Sony
- Tesla (TSLA) Offers to Acquire SolarCity (SCTY) for $26.50-$28.50/Share
Create E-mail Alert Related CategoriesLitigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!